SEC Filings | Tempest Therapeutics

Filing date	Description	Form	View
Sep 07, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-230659.pdf 0001193125-23-230659.rtf 0001193125-23-230659.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 10, 2023	Report of unscheduled material events or corporate event	8-K	0000950170-23-041385.pdf 0000950170-23-041385.rtf 0000950170-23-041385.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
Aug 10, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0000950170-23-041429.pdf 0000950170-23-041429.rtf 0000950170-23-041429.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
Jun 20, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-038440.pdf 0001209191-23-038440.rtf 0001209191-23-038440.xls View HTML
Jun 20, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-038443.pdf 0001209191-23-038443.rtf 0001209191-23-038443.xls View HTML
Jun 20, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-038448.pdf 0001209191-23-038448.rtf 0001209191-23-038448.xls View HTML
Jun 20, 2023	Statement of changes in beneficial ownership of securities	4	0001209191-23-038453.pdf 0001209191-23-038453.rtf 0001209191-23-038453.xls View HTML
Jun 16, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-169021.pdf 0001193125-23-169021.rtf 0001193125-23-169021.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 10, 2023	Report of unscheduled material events or corporate event	8-K	0000950170-23-020569.pdf 0000950170-23-020569.rtf 0000950170-23-020569.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
May 10, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0000950170-23-020579.pdf 0000950170-23-020579.rtf 0000950170-23-020579.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML

Click here to access archived Millendo Therapeutics SEC filings

Data provided by Kaleidoscope.